Orthofix beats Q3 sales estimates, narrows FY forecast
Orthofix reported Q3 net sales of $205.6 million, a 5% year-over-year increase, surpassing analyst expectations. Adjusted EBITDA rose 28.2% year-over-year. The company narrowed its full-year net sales guidance to $810-$814 million and raised the low end of adjusted EBITDA guidance to $84-$86 million. U.S. Spine Fixation sales grew 8%, and Orthopedics sales increased by 19%. Analysts maintain a "buy" rating, with a median 12-month price target of $23.00, reflecting a potential 30.2% upside from the recent closing price of $16.06.
)
Overview
- Orthofix Q3 net sales rose 5% yr/yr to $205.6 mln, beating analyst expectations
- Adjusted EBITDA for Q3 increased 28.2% yr/yr, beating analyst estimates
- Company narrowed full-year net sales guidance, raised low end of adjusted EBITDA guidance
Outlook
- Orthofix narrows 2025 net sales guidance to $810 mln-$814 mln
- Orthofix raises low end of 2025 adjusted EBITDA guidance to $84 mln-$86 mln
- Orthofix expects positive free cash flow for 2025, excluding M6 restructuring charges
Result Drivers
- SPINE FIXATION GROWTH - U.S. Spine Fixation net sales grew 8%, driven by 7D FLASH™ navigation technology
- BONE GROWTH THERAPIES - Bone Growth Therapies net sales increased by 6% due to effective cross-selling and leveraging access points
- ORTHOPEDICS LAUNCH - U.S. Orthopedics net sales grew 19%, aided by the launch of TrueLok™ Elevate
Key Details
Metric Beat/Mis Actual Consensu
s s
Estimate
Q3 Sales Beat $205.60 $200 mln
mln (5
Analysts
)
Q3 EPS -$0.57
Q3 Beat $24.60 $20.19
Adjusted mln mln (5
EBITDA Analysts
)
Q3 Gross 72.20%
Margin
Analyst Coverage
- The current average analyst rating on the shares is “buy” and the breakdown of recommendations is 4 “strong buy” or “buy”, 1 “hold” and no “sell” or “strong sell”
- Wall Street’s median 12-month price target for Orthofix Medical Inc is $23.00, about 30.2% above its November 3 closing price of $16.06
Press Release: For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact . (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
